4.7 Article

Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP): Five-year results of a randomized phase II trial.

Journal

JOURNAL OF CLINICAL ONCOLOGY
Volume 38, Issue 6_suppl, Pages 10-10

Publisher

American Society of Clinical Oncology (ASCO)
DOI: 10.1200/jco.2020.38.6_suppl.10

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available